Whistleblower policy and scheme
As BioInnovation Institute (BII) is funded by the Novo Nordisk Foundation, BII is covered by The Novo Nordisk Foundation and Novo Holdings A/S’ whistleblower policy and scheme. The purpose of the policy and scheme is to promote transparency and increase accountability for the behavior of BII and its collaborators by allowing people to report potential breaches of BII’s code of conduct anonymously.
If you wish to report breaches of BII’s code of conduct, you can do so through the URL below. For security reasons and to ensure anonymity, please type in the web-address in a new tab/window and gain access to the platform.